Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Hasenleithner Samantha |

** = Publications listed in SCI/SSCI/Pubmed

2024

Full paper/article (Journal)

** Lazzeri, I; Spiegl, BG; Hasenleithner, SO; Speicher, MR; Kircher, M LBFextract: Unveiling transcription factor dynamics from liquid biopsy data
COMPUT STRUCT BIOTEC. 2024; 23: 3163-3174. Doi: 10.1016/j.csbj.2024.08.007 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Review

** Hasenleithner, SO; Heitzer, E Liquid profiling for patients with advanced cancer is ready for clinical integration
MEMO-MAG EUR MED ONC. 2024; Doi: 10.1007/s12254-024-00978-6
Web of Science FullText FullText_MUG

 

** Klocker, EV; Hasenleithner, S; Bartsch, R; Gampenrieder, SP; Egle, D; Singer, CF; Rinnerthaler, G; Hubalek, M; Schmitz, K; Bago-Horvath, Z; Petzer, A; Heibl, S; Heitzer, E; Balic, M; Gnant, M Clinical applications of next-generation sequencing-based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression.
Mol Oncol. 2024; Doi: 10.1002/1878-0261.13671
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Moik, F; Riedl, JM; Edlinger, L; Esterl, T; Hasenleithner, S; Kostmann, S; Cebular, L; Jahn, S; Kashofer, K; Zacharias, M; Hoefler, G; Heitzer, E; Gerger, A; Jost, PJ Practice patterns and treatment outcomes of molecular tumour board (MTB)-based personalized cancer therapies: A single-center experience
ANN ONCOL. 2024; 35: S262-S263. Doi: 10.1016/j.annonc.2024.08.130
Web of Science FullText FullText_MUG

 

2023

Abstract (Journal)

** Dobric, N; Dandachi, N; Klocker, EV; Suppan, C; Graf, R; Hasenleithner, S; Jost, PJ; Heitzer, E; Balic, M Comparison of ctDNA profiles from HR+/HER2-low and HR+/HER2-0 advanced breast cancer patients
ANN ONCOL. 2023; 34: S387-S387.-Annual Meeting of the European-Society-for-Medical-Oncology (ESMO); OCT 20-24, 2023; Madrid, SPAIN. Doi: 10.1016/j.annonc.2023.09.667 [Poster]
Web of Science FullText FullText_MUG

 

** Riedl, JM; Steinlechner, SM; Moik, F; Heitzer, E; Jahn, S; Hasenleithner, S; Doleschal, B; Weiss, L; Seeber, A; Rumpold, H; Winder, T; Greil, R; Jost, PJ; Hoefler, G; Speicher, M; Gerger, A SOUND: A phase II trial evaluating the efficacy of molecular profiling of circulating ± tumor tissue DNA for salvagetherapy matching in patients with advanced and refractory carcinoma
ANN ONCOL. 2023; 34: S1186-S1186.-Annual Meeting of the European-Society-for-Medical-Oncology (ESMO); OCT 20-24, 2023; Barcelona, SPAIN. Doi: 10.1016/j.annonc.2023.09.1349 [Poster]
Web of Science FullText FullText_MUG

 

2022

Full paper/article (Journal)

** Horgan, D; Cufer, T; Gatto, F; Lugowska, I; Verbanac, D; Carvalho, A; Lal, JA; Kozaric, M; Toomey, S; Ivanov, HY; Longshore, J; Malapelle, U; Hasenleithner, S; Hofman, P; Alix-Panabieres, C Accelerating the Development and Validation of Liquid Biopsy for Early Cancer Screening and Treatment Tailoring
HEALTHCARE-BASEL. 2022; 10(9): 1714 Doi: 10.3390/healthcare10091714 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Short report/Letter

** Hasenleithner, SO; Speicher, MR How to detect cancer early using cell-free DNA.
Cancer Cell. 2022; 40(12): 1464-1466. Doi: 10.1016/j.ccell.2022.11.009
Web of Science PubMed FullText FullText_MUG

 

Review

** Hasenleithner, SO; Speicher, MR A clinician's handbook for using ctDNA throughout the patient journey.
Mol Cancer. 2022; 21(1): 81 Doi: 10.1186/s12943-022-01551-7 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2021

Full paper/article (Journal)

** Riedl, JM; Hasenleithner, SO; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stöger, H; Berghold, A; Hoefler, G; Speicher, MR; Heitzer, E; Gerger, A Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial.
Ther Adv Med Oncol. 2021; 13:1758835920987658 Doi: 10.1177/1758835920987658 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Weber, S; van der Leest, P; Donker, HC; Schlange, T; Timens, W; Tamminga, M; Hasenleithner, SO; Graf, R; Moser, T; Spiegl, B; Yaspo, ML; Terstappen, LWMM; Sidorenkov, G; Hiltermann, TJN; Speicher, MR; Schuuring, E; Heitzer, E; Groen, HJM Dynamic Changes of Circulating Tumor DNA Predict Clinical Outcome in Patients With Advanced Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
JCO PRECIS ONCOL. 2021; 5: 1540-1553. Doi: 10.1200/PO.21.00182
Web of Science PubMed FullText FullText_MUG

 

2020

Full paper/article (Journal)

** Moser, T; Waldispuehl-Geigl, J; Belic, J; Weber, S; Zhou, Q; Hasenleithner, SO; Graf, R; Terzic, JA; Posch, F; Sill, H; Lax, S; Kashofer, K; Hoefler, G; Schoellnast, H; Heitzer, E; Geigl, JB; Bauernhofer, T; Speicher, MR On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer.
NPJ Precis Oncol. 2020; 4(1):30 Doi: 10.1038/s41698-020-00134-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Perakis, SO; Weber, S; Zhou, Q; Graf, R; Hojas, S; Riedl, JM; Gerger, A; Dandachi, N; Balic, M; Hoefler, G; Schuuring, E; Groen, HJM; Geigl, JB; Heitzer, E; Speicher, MR Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancer.
ESMO Open. 2020; 5(5):e000872 Doi: 10.1136/esmoopen-2020-000872 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smith, CG; Moser, T; Mouliere, F; Field-Rayner, J; Eldridge, M; Riediger, AL; Chandrananda, D; Heider, K; Wan, JCM; Warren, AY; Morris, J; Hudecova, I; Cooper, WN; Mitchell, TJ; Gale, D; Ruiz-Valdepenas, A; Klatte, T; Ursprung, S; Sala, E; Riddick, ACP; Aho, TF; Armitage, JN; Perakis, S; Pichler, M; Seles, M; Wcislo, G; Welsh, SJ; Matakidou, A; Eisen, T; Massie, CE; Rosenfeld, N; Heitzer, E; Stewart, GD Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors.
Genome Med. 2020; 12(1): 23-23. Doi: 10.1186/s13073-020-00723-8 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Weber, S; Spiegl, B; Perakis, SO; Ulz, CM; Abuja, PM; Kashofer, K; Leest, PV; Azpurua, MA; Tamminga, M; Brudzewsky, D; Rothwell, DG; Mohan, S; Sartori, A; Lampignano, R; Konigshofer, Y; Sprenger-Haussels, M; Wikman, H; Bergheim, IR; Kloten, V; Schuuring, E; Speicher, MR; Heitzer, E Technical Evaluation of Commercial Mutation Analysis Platforms and Reference Materials for Liquid Biopsy Profiling.
Cancers (Basel). 2020; 12(6): 1588 Doi: 10.3390/cancers12061588 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Zhou, Q; Perakis, SO; Ulz, P; Mohan, S; Riedl, JM; Talakic, E; Lax, S; Tötsch, M; Hoefler, G; Bauernhofer, T; Pichler, M; Gerger, A; Geigl, JB; Heitzer, E; Speicher, MR Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer.
Genome Med. 2020; 12(1):20 Doi: 10.1186/s13073-020-0719-6 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Correction

** Ulz, P; Perakis, S; Zhou, Q; Moser, T; Belic, J; Lazzeri, I; Wölfler, A; Zebisch, A; Gerger, A; Pristauz, G; Petru, E; White, B; Roberts, CES; John, JS; Schimek, MG; Geigl, JB; Bauernhofer, T; Sill, H; Bock, C; Heitzer, E; Speicher, MR Publisher Correction: Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection.
Nat Commun. 2020; 11(1): 1965-1965. Doi: 10.1038/s41467-020-15799-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Journal)

** Gerger, A; Riedl, JM; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E Profiling of circulating tumour DNA for treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage phase II individualized cancer treatment trial.
ANN ONCOL. 2020; 31: S1095-S1096.-ESMO Virtual Congress; SEP 19-OCT 18, 2020; ELECTR NETWORK. Doi: 10.1016/j.annonc.2020.08.1331 [Onlinepräsentation] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Moser, T; Waldispuehl-Geigl, J; Belic, J; Perakis, S; Weber, S; Zhou, Q; Sill, H; Lax, S; Kashofer, K; Hoefler, G; Schoellnast, H; Bauernhofer, T; Heitzer, E; Geigl, JB; Speicher, MR Early circulating tumor DNA dynamics as a real-time predictor of FOLFOX efficacy in advanced colorectal cancer patients
CANCER RES. 2020; 80(16): Doi: 10.1158/1538-7445.AM2020-4295 [Poster]
Web of Science FullText FullText_MUG

 

** Perakis, SO; Weber, S; Graf, R; Zhou, Q; Riedl, JM; Dandachi, N; Balic, M; Gerger, A; Schuuring, E; Groen, HJ; Geigl, JB; Speicher, MR; Heitzer, E Identification of actionable targets in advanced cancer patients from circulating tumor DNA using clinical decision support platforms
CANCER RES. 2020; 80(16):-AACR Annual Meeting; JUN 22-24, 2020; ELECTR NETWORK. Doi: 10.1158/1538-7445.AM2020-1315 [Poster]
Web of Science FullText FullText_MUG

 

** Riedl, J; Perakis, S; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stoger, H; Berghold, A; Hofler, G; Speicher, M; Heitzer, E; Gerger, A Individualized cancer treatment based on molecular profiling of circulating tumor DNA in patients with advanced and refractory carcinoma: a prospective phase II trial.
ONCOL RES TREAT. 2020; 43(SUPPL 4):249-249.-DGHO Jahrestagung; 09.10. -11.10.2020; Basel (virtueller Kongress). [Oral Communication]
Web of Science

 

2019

Full paper/article (Journal)

** Ulz, P; Perakis, S; Zhou, Q; Moser, T; Belic, J; Lazzeri, I; Wölfler, A; Zebisch, A; Gerger, A; Pristauz, G; Petru, E; White, B; Roberts, CES; John, JS; Schimek, MG; Geigl, JB; Bauernhofer, T; Sill, H; Bock, C; Heitzer, E; Speicher, MR Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection.
Nat Commun. 2019; 10(1): 4666-4666. Doi: 10.1038/s41467-019-12714-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Journal)

** Moser, T; Smith, CG; Seles, M; Wcislo, G; Eldridge, M; Perakis, S; Mouliere, F; Lazzeri, I; Heider, K; Warren, A; Rosenfeld, N; Stewart, GD; Heitzer, E Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors.
CANCER RES. 2019; 79(13):-AACR Annual Meeting on Bioinformatics, Convergence Science, and Systems Biology; MAR 29-APR 03, 2019; Atlanta, GA. Doi: 10.1158/1538-7445.AM2019-1367 [Poster]
Web of Science FullText FullText_MUG

 

2018

Full paper/article (Journal)

** Belic, J; Graf, R; Bauernhofer, T; Cherkas, Y; Ulz, P; Waldispuehl-Geigl, J; Perakis, S; Gormley, M; Patel, J; Li, W; Geigl, JB; Smirnov, D; Heitzer, E; Gross, M; Speicher, MR Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide.
Int J Cancer. 2018; 143(5): 1236-1248. Doi: 10.1002/ijc.31397 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Review

** Zhou, Q; Moser, T; Perakis, S; Heitzer, E Untargeted profiling of cell-free circulating DNA
TRANSL CANCER RES. 2018; 7: S140-S152. Doi: 10.21037/tcr.2017.10.11
Web of Science FullText FullText_MUG

 

Abstract (Journal)

** Belic, J; Graf, R; Bauernhofer, T; Cherkas, Y; Peter, U; Waldispuehl-Geigl, J; Perakis, S; Gormley, M; Patel, J; Li, WM; Geigl, JB; Smirnov, D; Heitzer, E; Gross, M; Speicher, MR Analysis of circulating tumor DNA reveals genomic alterations in metastatic prostate cancer patients treated with abiraterone acetate plus prednisone or enzalutamide
CANCER RES. 2018; 78(13):-Annual Meeting of the American-Association-for-Cancer-Research (AACR); APR 14-18, 2018; Chicago, IL. Doi: 10.1158/1538-7445.AM2018-2959 [Oral Communication]
Web of Science FullText FullText_MUG

 

2017

Full paper/article (Journal)

** Perakis, S; Auer, M; Belic, J; Heitzer, E Advances in Circulating Tumor DNA Analysis.
Adv Clin Chem. 2017; 80(10):73-153 Doi: 10.1016/bs.acc.2016.11.005
Web of Science PubMed FullText FullText_MUG

 

Short report/Letter

** Moser, T; Ulz, P; Zhou, Q; Perakis, S; Geigl, JB; Speicher, MR; Heitzer, E Single-Stranded DNA Library Preparation Does Not Preferentially Enrich Circulating Tumor DNA.
Clin Chem. 2017; 63(10):1656-1659 Doi: 10.1373/clinchem.2017.277988 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Review

** Heitzer, E; Perakis, S; Geigl, JB; Speicher, MR The potential of liquid biopsies for the early detection of cancer.
NPJ Precis Oncol. 2017; 1(1):36-36 Doi: 10.1038/s41698-017-0039-5 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Perakis, S; Speicher, MR Emerging concepts in liquid biopsies.
BMC Med. 2017; 15(1):75-75 Doi: 10.1186/s12916-017-0840-6 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Journal)

** Graier, T; Auer, M; Heitzer, E; Ulz, P; Perakis, S; Speicher, MR; Geigl, JB Rapid single-cell copy-number aberration analysis using high- throughput sequencing.
EUR J CANCER. 2017; 72: S24-S24.-ECCO European Cancer Congress; JAN 27-30, 2017; Amsterdam, NETHERLANDS. Doi: 10.1016/S0959-8049(17)30159-4 [Poster]
Web of Science FullText FullText_MUG

 

2016

Review

** Perakis, SO; Thomas, JE; Pichler, M Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients.
Adv Exp Med Biol. 2016; 937(4):183-204 Doi: 10.1007/978-3-319-42059-2_10
Web of Science PubMed FullText FullText_MUG

 

** Seles, M; Hutterer, GC; Kiesslich, T; Pummer, K; Berindan-Neagoe, I; Perakis, S; Schwarzenbacher, D; Stotz, M; Gerger, A; Pichler, M Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma.
Int J Mol Sci. 2016; 17(4):573-573 Doi: 10.3390/ijms17040573 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Full paper/article (Journal)

** Ress, AL; Perakis, S; Pichler, M microRNAs and Colorectal Cancer.
Adv Exp Med Biol. 2015; 889(6):89-103 Doi: 10.1007/978-3-319-23730-5_6
Web of Science PubMed FullText FullText_MUG

 

2014

Full paper/article (Journal)

** Ress, AL; Stiegelbauer, V; Schwarzenbacher, D; Deutsch, A; Perakis, S; Ling, H; Ivan, C; Calin, GA; Rinner, B; Gerger, A; Pichler, M Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer.
Oncotarget. 2014; 5(18):8492-8502 Doi: 10.18632/oncotarget.2329 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Review

** Stiegelbauer, V; Perakis, S; Deutsch, A; Ling, H; Gerger, A; Pichler, M MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.
World J Gastroenterol. 2014; 20(33):11727-11735 Doi: 10.3748/wjg.v20.i33.11727 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2012

Full paper/article (Journal)

** Pitroda, SP; Zhou, T; Sweis, RF; Filippo, M; Labay, E; Beckett, MA; Mauceri, HJ; Liang, H; Darga, TE; Perakis, S; Khan, SA; Sutton, HG; Zhang, W; Khodarev, NN; Garcia, JG; Weichselbaum, RR Tumor endothelial inflammation predicts clinical outcome in diverse human cancers.
PLoS One. 2012; 7(10): e46104-e46104. Doi: 10.1371/journal.pone.0046104 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2011

Full paper/article (Journal)

** Lussier, YA; Xing, HR; Salama, JK; Khodarev, NN; Huang, Y; Zhang, Q; Khan, SA; Yang, X; Hasselle, MD; Darga, TE; Malik, R; Fan, H; Perakis, S; Filippo, M; Corbin, K; Lee, Y; Posner, MC; Chmura, SJ; Hellman, S; Weichselbaum, RR MicroRNA expression characterizes oligometastasis(es).
PLoS One. 2011; 6(12): e28650-e28650. Doi: 10.1371/journal.pone.0028650 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

↑ Top of page / Navigation

© Med Uni Graz • Imprint